Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study Pharmaceutical Investing
Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results Pharmaceutical Investing
Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update Pharmaceutical Investing
FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment Pharmaceutical Investing
Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results Pharmaceutical Investing
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
